ࡱ> FH?@ABCDE9 R^bjbj2nl""3" |||||||O ob| |cMcMcMcMD_|cM|cMpcMRVW "Y"&rWW<%03WфaHфWcM""-NVؚ@S2lcWS2005t^OHrhQe -NVؚ@S2lcWSOYXTO \O;NNYXTRRu 2005-10-25 18:59:29 -NVؚ@S2lcWSOYXTO ;NNYXTRRu oR;NNYXTpQu -NVؚ@S2lcWSOYXTOYXT T[up e ;W s e swmq ~[NS 1go 1g O YOV 4TFQς _~_ hTSQ gU, Y]NS *m-fIQ N v 8n Q [ *m ĖN Xos -NVؚ@S2lcWSf[/gYXTOYXT T[upe ;Ws es stQ[swmqs~IQ[0uwmQ^zRRuRVhNS &tT~NTSSNY[[s1g O1gf1go~[NSYOV4T [4TS54TFQς4Twm4T!Bh _  _[n _^pg _~_NgNwNgIQONgOjlSel^oNSHpQH%ffhTSQgU,fk30Nё[INY]NS*m-fIQ'YNu Qvf)R_beNY1cz;{~NΘ~ Yuؚmbe*Ğ \pQu`]l*Yfckj8n Q[ *mĖN"KfXnXos4bsNS4bgO\KNMR 0-NVؚ@S2lcWS 0OHr (WY!k^l_BlTf[yN[avW@x N 1ubV20YOMO_@{00QRl0^y~y0YN0L:N0%{Q0{tN[~bvYXTOSeNt^OQ[b0 ,g!kcWSvO/f9hncbVяt^egv_@{AmLuf[T_;Sf[vۏU\ v^SPtNVYgexvzbgTcWS^ 02003t^WHO/ISHؚ@SYtcWS 00 яt^eg 1uN>yO~Nmv_SU\TNNu;me_vSS bVv_@{uSusSvsQqSiV }GW gXvR0nc2002t^hQVE\l%{QNeP^rQgDe>f:y bVbNؚ@S`us:N18.8, hQV gؚ@S`~1.6N0FOؚ@SvwSfs0lusSc6RsGW_NO bNb4Nvؚ@S2lNR/f^8^p]v0,gcWSNbVؚ@SAmLrQT2l[EQS cQ&{TV`vhQNTؚqSNv~Tv2lV{eu :_N2l TeR:_ؚ@SuNvlu0 ؚ@SvqS['`dN`v@S4ls^vsQY ؏SQN TeX[(WvvQ[_@{qSiV }NSTv^vvQ[uu`Q0Vdk (Wؚ@Sv[INNR{|-N dN\ؚ@SvʋehQ[(W6e)Se"140mmHgT/b _Se"90mmHg 9hnc@S4ls^R:Nck8^0ck8^ؚyO~Nm`Q 9hncbVvsr SOvlu^/f=\S(WN,ؚ@S`-NcPO(u^NvMSoir HQcؚlus 6qT(WdkW@x Nekcؚc6Rs04N^;S^SN9hnc`vu` b)R?\BR0b;nBR0bbBR0@{'} _ }lbcvb6RBRACEI b@{'} _ }IISSOATB1B bbBRARB vNybNyN N b1u Noir~bvV[BRϑ YeMS6RBR0:NO@Sh 'YYpeؚ@SuN$Nyb$NyN NMSoTT^(u0 2004t^-NVؚ@S2lcWSp: p1 cWSvON:_vplbVNؚ@S`usHTXR 0OhQV gؚ@S`1.6N FOؚ@S wSfs0lusTc6RsNO0 lc6Rؚ@S/f2_@{uv;Nce0RS-N/fZbVNleP^v͑'Y uu c6Rؚ@S/f2RS-NvsQ.0 lluvv/fǏMSluOؚ@S`v@Sh Ngg'YP^0WMNO_ @{SuT{kNv;`qSi0l9hncqSiRB\ nx[lueHhl@SN110/75mmHgw N@S4ls^GSؚN_@{uqSiHTޏ~'`ckvsQ0lck8^ؚy:S:N-N_ \ؚ@S2lv?eV{0ce0bgT~Sb>y:S[0NkSulT>yOqQ TSN EQRS%c?e^Tv^0NNVSO0ON0eZNS>yOTLuv\O(u ^z^lvؚ@S2lTvT~Nb~0 0-NVؚ@S2lcWS 0OHr:NbV21N~vؚ@S2]\OT4N^[cfNeT0:NOcWSvSRSbLR ?e^0f[/gVSONS>yOTLuhQeMOv/ecMT O2lN~v]\ONXTw/{_ gRN^'YWaNE\l :N\bVؚ@S2lcؚ0Rev4ls^ZP!.s0 2004t^ -NVؚ@S2lcWSOYXTO9hncbVяt^egv_@{AmLuf[T_;Sf[vۏU\,SVQ0YgexvzbJTTcWS [1999t^ 0-NVؚ@S2lcWS 0ۏLO02004t^^HQLShR?z[(u,g S Y_BlaW@x N 2005t^hQeSh0 1Nؚ@SAmL`Q ؚ@S/fNySvuu N~vYt^MRRiva-RocciSfN&^@ST;Sf[LuMb[ؚ@SvutTutaIN gNƋ020N~50-60t^N_U\N'YϑN@SR^S@SN_@{usQ|vAmLuf[T4N^xvz [Nؚ@S/f_w_@{uv;NqSiV }0xvzؚ@SvAmLyr_ HQ㉳Qv/fؚ@SʋehQvnx[0N@SvR^cяck`R^0YUOnx[ؚ@STck8^@SvRLup(cutoff point) Nv/fؚ@SAmLuxvzv͑p0Nt N RLupvnx[/fN:Nv FON4N^҉^ w ُ*Np^/f:S+R gu T eu vgsOp0ُTnx[NUOHTck`R^vutchck8^fvsQ0 N TyeTleKN@S gN[vSO]_0 1.2 bVNؚ@S`usSvQSSR bVfۏLǏ N!k'Yĉ!jؚ@SNb7hg01958-1959t^,{N!kgRw^ qQg15\N NN~50N0S_eT0WǑ(uvʋehQ NN R N~b/g=T Ee*g_0R|nxv`uspenc0|eu0W{ s^GW`u|s:N5.101979-1980t^,{N!khQVb7hg qQg15\N NN~400YN0Ǒ(uNS_evNLukSu~~hQe"160/95 mmHg:Nnxʋؚ@S 140/90mmHgT160/95mmHgKNv:N4NLuؚ@S 01uNS_et g l gb@S

f0WS fNbVNؚ@S`usv NGSR0yr+R/f,{N!kT,{ N!kg Ǒ(uN T7hvt^~T@SKmϑel0(WǑ(uN TNhQ,{N!kgvhQ Tpenc[hQSk0~g>f:y N1980t^0R1991t^v10t^ bVNؚ@S`us NGSN4.15*N~vRp ~[180/110mmHge _@{SuqSiXR10 P0 яt^eg 1uN>yOSiTNNu;me_vSS bV_@{uSusSvsQqSiV }GW gXRR0nc2002t^kSu~~vhQVE\l27NN%{QNeP^rQgDe>f:y bVE\lߘ(ϑf>fcؚ FOW^E\lߘ~g N=\Tt0\u{|Sl{|m9ǏY ba'`^ Og'`uu`us NGSŏ0bV18\SN NE\lؚ@S`us:N18.8 0OhQV`uNpe1.6NY0N1991t^k `us NGS310bVNؚ@SwSfs:N30.2 lus:N24.7 c6Rs:N6.1 N1991t^k g@bcؚ FONYN]4ls^0bV18\SN NE\l|?\u`us:N2.6 zzy@|S_cs:N1.900OhQV|?\us`Npe2000YN S gя2000NNzzy@|S_c0N1996t^k 'YW^20\N N|?\u`us1u4.6 NGS0R6.4 XR390bVbN@_8^`us:N18.6 0OhQV@_8^s`Npe1.6N vQ-NؚƀV@u2.9 ؚul No@u11.9 NOؚ[^ˆ}v@u7.40bVbN͑s:N22.8 րs:N7.1 0OhQV͑Npe2.0N րNpe6000YN0?Qzրs]8 ^NN͑Ɖ0N1992t^k bN͑s NGS39 րs NGS970ghf ߘؚϑ0ؚT\SOR;mRN͑0ր0|?\uT@_8^vSu[RvsQ ؚvnߘNؚ@S`u[RvsQ nRNؚ@ST@_8^v`u[RvsQ DdeQYNSOR;mR\vN ` Nba'`uuv:gOY0 1.3 bVNؚ@Su`vؚ@SwSfs0lusTc6Rs ؚ@SwSfs0lusTc6Rs/fؚ@SAmLuf[T2lxvzv͑Spe01991t^hQV@Sb7hg6eƖN gsQNؚ@SwSfs0lusTc6Rsvpench1-N1991t^De _-NVؚ@SBg_1995t^X R 17u 0 h1 1991t^, 2002t^bVNؚ@S`wSfs0lusTc6Rs ؚ@SNpewSfs*  gos* c6Rs* 1991t^ W^ 7u sY T 37820 35752 73572 32.1 39.4 35.6 14.7 19.7 17.1 3.3 4.9 4.1QQg 7u sY T 26816 28651 55467 11.7 15.9 13.9 4.4 6.4 5.4 1.0 1.4 1.2;`12903926.312.12.82002t^;`2980030.224.76.1* 2002t^v[INwSfs:NSʋe:Nؚ@Svg[a(WgMR1\wS]` gؚ@SvkO lus:NSʋe:Nؚ@Svg[a-Nя2hTQ gMSovkO c6Rs:NSʋe:Nؚ@Svg[a-NvMRǏlu@S(W140/90 mmHgN NvkO0 h1 vpenchf vMRbVNؚ@S`vؚ@SwSfs0lu go sTc6Rs_NO0dkY QQgvv^Tsf>fNONW^ 7u'`NONsY'`0V20N~80t^NvDe>f:y Nؚ@S`wSfs:N60 gos:N40 c6Rs252000t^N N NsR+R70 59T340 N NAmLuf[De>f:y яJS*NN~egbVNؚ@S`us NGS__0vQNxvzDe؏hf _@{uvvQNqSiV }@_8^0ր0|?\u08TpI{ _NHTf>f NGSR R_Nؚ@SvuǏ z0[ؚ@STvQNqSiV } NGSv;NSV/f1uNbV~NmSU\ Nlu;m9eUTu;mOYvR_&^egvN|R NeP^u;me_@b0vQ-Ng͑v/fߘ Ns^a 8TpTǏϑnR :ONSOR;mRT_tSRXR0ُN NoR NS_NOvNؚ@Sc6Rs /f[bVNؚ@S2lvN*N%N͑vcb _N/fN*N:gG0kN T;SR]\O[bVؚ@SvAmL`RSvQ\[vTg_{ gnvƋ Ocؚ^vfɉ v^ǑS gRv2lce0 1.4 _@{ub:N-NVNMO{kV ؚ@S/f,{NqSiV } gяShvbVe"40\17NN8t^123 9191N-t^ ~ghf ;`{kN20 033N ;`{kNs:N1345.2/10NN-t^0MR NMO{kNvSV{kNs/10NN-t^ R+R:N_u296.3 0v`'`$v293.3 0@{u276.9 0;`{kNvqSiV },{NMO/fؚ@Sv[qSiRR=1.48 ,dkT/f8TpRR1.23 T:ONSOR;mRRR=1.20 0_u`S;`{kNv23.1 v`'`$v`S22.3 @{u`S21.30_@{uTv^`S;`{kNv44.40 ؚ@SSvsQuuvb/f]'Yv nc2003t^~bVؚ@Svc;Su9:N300NCQNl^ @{u:N263NCQ _u:N288NCQ0nc0ObV_@{ukt^9vc;Su9Tc9 3000NCQNl^0 2. @SN_@{uqSi @S4ls^N_@{uSusHTޏ~ckvsQ0YNؚ@S gsQuuSuN8^:N/f ck8^@S  Vdk ؚ@S`_@{uqSi NNSQN@S4ls^ ؏SQN TeX[(WvvQ[_@{qSiV }vpeϑT z^0 2.1 ؚ@SSuvqSiV } VElQvؚ@SSuqSiV }/f ͑0ؚvߘS-N^N NnR0bVAmLuf[xvz_N[ُ N'YV }Nؚ@SSu>fWvsQ FOST gvQyrp0 2.1.1 SO͑͑TրbyWր -NVbNck8^SO͑cpeBMI: kg/mP2P :N19~24 SO͑cpee"24:N͑ e"28:N:Nր0NSO͑cpev]+R[Nv@S4ls^Tؚ@S`us g>fWq_T0bVN@S4ls^Tؚ@S`usSeؚNWSe NNSO͑cpe]_vs^L0W~SO͑cpekXR3 4t^QSuؚ@SvqSisY'`XR57 7u'`XR500 yWր-NVbN N"~T_ pVRpvxvzhf bV-Nt^N@wpVX'Y  N"~T_ bRZƖvOR

fWXؚyZƖTqSiV }vXR g[RsQ|0N7u'`pVe"85cm0sY'`e"80cm:NRp hQ N"~T_ vGP3'`sTGP4'`sv[NO0 bV24NbNpencGl;`Rghf BMIe"24kg/mP2P`ؚ@SvqSi/fSO͑ck8^v3~4 P `|?\uvqSi/fSO͑ck8^v2~3 P wQ g2yS2yN NqSiV }vؚ@SS|?\uqSi/fSO͑ck8^v3~4 P0BMIe"28kg/mP2Pvր-N90N N` Nuub gqSiV }ZƖ07u'`pVe"85cm0sY'`e"80cmؚ@SvqSi:NpVNONdkLuPv3.5 P vQ`u?\uvqSi:N2.5 P vQ-N g2yS2yN NqSiV }ZƖvؚ@SS|?\uqSi:Nck8^SO͑v4 PN N0 gя VE|?\uTvlQ^v N"~T_ gsQyWրvhQ/f-NVNpV7u'`e"90cm0sY'`e"80cm0 gsQy营րvpVvMRf(u-NVր]\O~^vhQ FO(W N Tvxvz-NS TeSVE|?\uTvvhQ0 gsQ-NVy营րvpVhQNۏNekxvz0 h2 -NVbN͑TրvSO͑cpeTpVLuPfWvsQ'` SeN@S4ls^ؚNWSe0(Wc6RN;`pϑT ߘN6e)SS _SvvsQ|peR+R0R0.63S0.580Ns^GWkNk)YDdeQߘvXR2g R6e)ST _SR+RGSؚ2.0mmHgS1.2mmHg0 2.2@SGSؚ/f_@{SuvqSiV } @SGSؚ/fRS-NTQ_uSuvrzqSiV }0 2.2.1@SGSؚ/f-NVNRS-NSuvg͑qSiV } bV:NRS-NؚSV 1997t^ WHO-MONICAxvzbJTSN35~64\7u'`RS-NNNSus:N247/10NN sY'`:N175/10NN0bV10~Nxvzhf @S4ls^NRS-NSuqSiHT[pe~'`sQ| W~6e)SkGSؚ10mmHg RS-NSuv[qSiXR49:@'`RS-NXR47 Q@'`RS-NXR54  _SkGSؚ5mmHg RS-NqSiXR460NNNRg>f:y -NVTe,gN-N @SGSؚ[RS-NSu\O(u:_^:NeNv1.5 P0bVvxvzc:yt^@{u`W@xTglu-Ns^GW6e)S4ls^NRS-NQS gsQ0-NVNW^RS-N2xvzhf@S4ls^NRS-NSuqSi[RvsQ 6e)SkGSؚ10mmHg RS-NqSi1\XR250>y:Sr^luSORS-NSuqSi NM310 2.2.2@SGSؚ/f-NVNQ_uSuvqSiV } @SGSؚ/feNQ_uvrzqSiV } _fIl_xvzSMRFITxvz]~[0lQS7u'`Q_uqSiV }vMRw'`xvz>f:y 6e)S120~139mmHge Q_uv[qSik<120mmHgXؚ40 140~149mmHgXR1.3 P T7hf@SGSؚ(W-NVN-N[Q_uSuv\O(u0@S%`gRGSؚSS%`'`_h{k0 2.2.3@SGSؚXR_RpzTuuvqSi gؚ@SuSv_RpzqSikeؚ@SuSؚ6 P0 _SkMNO5mmHg SOSu~+gguvqSiQ\1/40nc-NV_@{eP^xvzg bV_Rpz`us:N0.9 0OhQV g_Rpz`400N0 2.2.4 S[t^N_@{Suvq_T0 SX'Y/fS fR 9_'`]vch0Syst-China0Syst-EurTEWPHEI{t^Nؚ@SՋGl;`Rghf 60\N Nt^NW~ SN;`{kN _@{'`{kN RS-NTQ_uSuGWHT>fWckvsQ0bVvxvzc:yt^@{u` S4ls^NRS-NQS gsQ0 2.3 _@{uSuvvQ[qSiV } _@{Su/fYyqSiV }~T\O(uv~g QyqSiV }-N^GSؚe[_@{Suv~[qSiSǏUSrNyqSiV }ؚ^GSؚ bvqSi0bN(WQؚ@SuNvlueTR^e NN^9hncvQ@S4ls^ ؏^ TeQvQ[qSiV }0_@{SuvvQ[qSiV }Y N 2.3.1t^ _@{Sut^ GSؚ0YSN35-74\E\l t^kX10\ Q_uSusXؚ1~3 P RS-NSusXؚ1~4 P0ُ/f1uNYpeqSiV }4ls^t^vX GSؚ }6qt^'YXؚv^ g@bQba FO1uNt^Susؚ Ee~[qSiN_ؚ0 2.3.2'`+R 7u'`_@{SusؚNsY'` bV14*NNvKm5t^~g>f:y 25~74\7u'`Q_u RS-NSusR+R:NsY'`v1.1~6.2T1.2~3.1 P0 2.3.38Tp 8Tp/flQv_@{uuSuv͑qSiV }0bV10~RNMRw'`xvzhf 8TpQ_uSuvv[qSik N8TpXؚ2 P :@'`RS-NqSiXؚ1 P Lvu{kNqSiXؚ45 ;`{kNqSiXؚ210SNDehf 8Tp;`ϑkXR1 P %`'`_h{kSuqSi1\XR4 P0 2.3.4@_8^ @n;`ƀVTC TNO[^ˆ}vƀVLDL-C GSؚ/fQ_uT:@'`RS-NvqSiV }07u]@TC 200~239mg/dl Q_uSuqSi:NTC<200mg/dlv2 P >240mg/dlvSuqSi:N<200mg/dl3 P0 NwmN~L]De_Nhf }6q@TC4ls^NONe FOvQNQ_u{kNvv[qSiNHT[pe~'`sQ|0f@TC\O:NQ_uSuvqSiV } l ggNOf:y N-Nؚ[^ˆ}vƀVHDL-C GWfWvsQ0 2.3.5͑Tր ͑Tր/fؚ@SSuvqSiV } Te_N/fQ_uTRS-NSuvrzqSiV }0bVNSO͑cpeBMI 4ls^}NONe FOяt^egX_0bVNBMI4ls^N_@{uSu[RvsQ0W~eBMIkXR1kg/mP2P Q_uSuqSiXؚ12 :@'`RS-NqSiXؚ60c:y͑Tր/fbVNQ_uT:@'`RS-NSuvrzqSiV }0 2.3.6 |?\uT\ }bb |?\u/fR |7hlxS'`uuvfnxqSiV } _N/fQ_uvI{qSu0nc1994t^20YONNg bV|?\u`usT|ϑ_8^`usR+R:N2.5T3.2 k10t^MRXN3 P02002t^g_Nc:y'YW^20\N N|?\u`usk1996t^X390|?\u`vBMI pVkO @S4ls^GWؚN^|?\u0bVDe؏>f:y @n\ }4ls^N_@{uvYqSiV }>fWvsQ Yؚul No NOHDL-C ͑Tր ؚ@S0ؚ@nƀVTؚ?\xI{0'Y^xvzDehf|?\u~Q_uSuNpe/f|ϑck8^v10 PN N0T@|Sm^NQ_uSuHTckvsQ0 2.3.7 C-S^ˆ}v N\xvzhfC-S^ˆ}vN_@{Su gsQ SKm_@{NNvSu vQKmvRNLDL-CN7h:_0C-S^ˆ}v؏N N"~T_ [RvsQ0؏ۏNeky/}VQvxvzDe0 2.3.8:\SOR;mR SOR;mRQ\/f b͑/րv͑SVKNN0SNT^]ʐ:SQlvxvzhf lTaNGONS_]Nb^QNRRvQlNc~0uRRk BMI>fWXؚ _@{vQ[qSiV }_N>fWXؚ0:\SOR;mRSXRؚ@S`_@{uSuqSi0 2.3.9_@{uuS uuS g_@{u[eS `,gN g_@{uSYRS-N _h{k _pI{ buuS GWSXR_@{uSuqSi0 3ʋe'`ċ0O ċ0OSb Neb t$ nx[@S4ls^SvQ[_@{uqSiV } u$ $Reؚ@SvSVfnx ge~S'`ؚ@S v$ [~bvhV[_c[NSvsQ4N^v`Q vv/f)RNؚ@SSVvt+Rʋe0_@{qSiV }vċ0O v^c[ʋeceST$Re0@bOo`egꁣ`v[eS0uS0SOuSO{|bpo0uII{l_t>yOV }~NSq_Tؚ@Su zSuHev*NN_t0>yOTsXV } Sb[^`Q0]\OsXSeS z^0 3.2SOuSO{|bpo0O~ ~ހu }0sb[̃ } l5S'`QWl04Yu0&qQ0_`U~ހ$v l5S'`eRTucVnXYu 3.qSiV } lؚ@ST_@{uuv*NNSb[eS l@_8^v*NNSb[eS l|?\uv*NNSb[eS l8Tp`N` lnߘ`N` lր;mRϑ l'`el0(W_sba >els^fbaN0_ _SpeT _>el0 z$(W>elǏ z-NN~,TSgl ‰[gl,{`!ev,{N T,{Vevm1Y 4lgQbvWvؚ^06e)SpeSgl,{`!ev  _SpeSgl,{Vev0<12\?Qz0Y ZYsY0%N͑+@02urzRNۏ0;NR tsQ NhQSgl Nm1Y Ngl,{IVevS [:N _S0 {$@SUSMO(W4N^O(ueǑ(uks|^lgmmHg (WbVck_QHrir-Nlfks|^lgNCS^eaSkPa vbc{sQ| lmmHg=0.133kPa0 |$^v1-2R͑ YKmϑ S2!kpevs^GWPTN^(u24\es^GW@S0 3.5 [~bvhV[_c[SgN4N^`Q vhV[_c[[ؚ@SuN;`_@{uqSiv$Re/fASR͑v Ee^N~[~bvhV[_c[vnc0 3.5.1__5uVhge(WSs_:@0_ O[;nT__1Y8^S][S0X_RVʋe][STKm_@{qSieuON_5uV0xqQ/c0_ TMO }>fP0ЏRՋTQrR q_(W gyrk^eYʋeQ_u S^(u0X~hg_N/fNy g(uvʋeelN_n^0'YR b_s`Q 0 3.5.2@{XcKmR Q-NB\S^IMT TeWWS gKmRS-NT_h{kvSuvN416mmol/L7mg/dl ]8^N*gluvؚ@SuN0ؚ?\x@uNlxSuvsQ0@nPSm^GSؚc:y\tnǏsQ\ cQ}vˆ}vXRc:y\tǏnO\R }qN0_ϑ}vˆ}v?\:_pc:y1WT2W|?\u`QsNۏU\'`|?\uu ˆ}v?\8^c:y[(_c[0^|?\uvؚ@SuN4O g_}vˆ}v?\ [_@{NN gKmNfWNO N<1ng/ml/h N@FmVn4ls^f>fXؚc:yu0@FmVnng/dl N@Fm };m'`ng/ml/\e k110nmol/L40ng ؚ^c:y,gu0 3.6.6oirSvؚ@S GSؚ@Svoir guI0S gU[o0{|V0^>uSObpo0SaSV0[^Nf0O~~ހub }Tsb[̃ }I{0 3.7W Of[Rg W Of[Rg(Wؚ@SuNv8^ĉċN-N@bw\O(u\ Nfnx0ؚ@SuN8^ g[eS c:yW OV }[ؚ@SvSu:g6R gN[\O(u0ؚ@S/fNyYuVvYWVuu0WVRg[nxbcdUvUSWVW O'`ؚ@S gN[Nf:yt^N SX'Y/fk6e)ST _Sf͑v_@{NNvKmVP[ t^NW~ SN;`{kN _@{'`{kN RS-NTQ_uSuGWHT>fWckvsQ0 gsQ:gՋ_NfMSlu[US~US~6e)gؚ@S`/f gvv0 tN] gvN|R'YW:g[gqՋGW/ec[US~6e)gؚ@ST _gؚ@S`NNlu Vdk (W4N^[-NbNN^S_(u6e)ST _S4ls^c[lu0(WMSuHeċ0O-N^la[6e)ST _SuHevhQbċ0O0ؚ@SR~TqSiċ0Oh30h5 vv(WN^(u6e)ST _S[@S4ls^T;`qSiۏLRB\0s(Wvؚ@SR~TqSiRB\N6q/fNy{US [(uvel0 4.2 c@S4ls^R{| @S4ls^N_@{SuqSiKNvsQ|/fޏ~v Vdk [ؚ@SvNUOpeW[[INTR{|GW/ffkev0ؚ@SvNUOpeW[[IN_{/fup;mv ^9hncluo gHe'`TS'`SqSi'`ؚNOv N T g@b N T0 @SR:Nck8^0ck8^ؚ 55\ _5uV( 200mg/dL):@'`RS-NsY'` > 65\X_RVLVMIT@| e"11.1mmol/L Q@8TpbX~( 126mg/dL)wf'`:@S\O@_8^R XXS_uuTCe"5.7mmol/LR XIMTe" 0.9mm _h{kS 0 220mg/dL bR |7h lxS'`eWW_~ubLDL-C > 3.6mmol/LvXhsQrR @Џ͑ ^ 140mg/dL @nP{ ^GSؚEQ@'`_Rpz 0 bHDL-C < 1.0mmol/L7u'`115~133mmol/Luu40mg/dL 1.3~1.5md/dL |?\uueS_@{u[ eSsY'`107~124mmol/LRS_c @nP N~N^\ Sut^ < 50\1.2~1.4mg/dL 7u'` > 133mmol/LyWրbր_ϑ}vˆ}v?\(1.5mg/dL)yWր *WC 7u'` e" 85cm?\}vˆ}v30~300mg/24hsY'` > 124mmol/LsY'` e"80cm}vˆ}v/Pk(1.4md/dL)րBMI e" 28kg/mP2P7u'` e" 22mg/gˆ}v?\ > 300mg/24h :ONSOR;mR 02.5mg/mmol YhT@{uusY'` e"31mg/gؚOeCS^ˆ}v e"3mg/L bCS^ˆ}v e" 10mg/L3.5mg/mmol ƉQuSQ @bnQ ƉsN 4Y4lTC;`ƀVLDC-CNO[^ˆ}vƀVHDL-Cؚ[^ˆ}vƀVLVMI][(ϑcpeIMTR Q-NB\S^BMISO͑cpeWCpV0*:N-NVր]\O~hQ h4RQNqSiRB\-N8^(uvqSiV }0vhV[_c[0|?\uTv^X[v4N^`Q0[1999t^cWSv^Q[vfe;NSOs(WN NQ*Neb t$ qSiV }XRN y营ր zQ:_N[/f N"~T_ v͑SO_KNN u$ |?\uR(WUSrNh ;N/f:NN:_[\O:NqSiV }v͑'`N^|?\uuNvk \OqSiXRN1 P  v$ _ϑ}vˆ}v?\_NƉ:NvhV[_c[v_aKNN ˆ}v?\/fuuv^X[4N^`Q vhsKNN w$ @nP{^GSؚ107-133mmol/L 1.2-1.5mg/dL /fvhV[_c[vyr_KNN @nP7u>133mmol/L1.5mg/dL 0sY>124mmol/L1.4mg/dL R:NR NhQ R_:Nv^X[4N^`Q x$ C-S^ˆ}vNR:NqSiV }bh_ir V:NegYvnchf C-S^ˆ}vKm_@{NNvR\NNO[^ˆ}vƀVLDL-C N7h:_ N؏N N"~T_ [RvsQ y$ vhV[_c[-N RdƉQR nfM'`b@\vp'`rz V:Nُy_a(W50\N NvN-NASRnfM FO30 \O:N-NVNvhQ \ؚ0ObVNvqSi Ee\_[ NhQۏLċ0O Ng~nx[TbVvqSi^v[IN0 cqSi^\`R:NN N4~ 4.3.1NOqS~ 7u'`t^<55\0sY'`t^<65\ ؚ@S1~0evQNqSiV } ^\NOqS~0xQW`Q N 10t^-N`Su;N_@{NNvqSi<150 4.3.2-NqS~ ؚ@S2~b1~2~ Te g1~2*NqSiV } uN^&T~Noirlu _YoirluMR^~Yev‰[ ;SuNASR[v$Re0xQW`Q N ~`T10t^QSu;N_@{NNvqSi~15~20 傣`^\ؚ@S1~ |Q gNyqSiV } 10t^QSu_@{NNqSi~150 4.3.3ؚqS~ ؚ@S4ls^^\1~b2~ |Q g3ybfYqSiV }0|Q`|?\ubvhV[_c[bؚ@S4ls^^\3~FOevQNqSiV }`^\ؚqS~0xQW`Q N NNT10t^Su;N_@{NNvqSi~20~300 4.3.4_ؚqS~ ؚ@S3~ Te g1yN NqSiV }b|Q`|?\ubvhV[_c[ bؚ@S1~3~v^ g4N^vsQuu0xQW`Q N T10t^Su;N_@{NNvqSigؚ e"30 ^ŏ_Ygygvlu0 _fIl_xvzDe(uNVT'k2m NN[[hQTNbV0bVf[RgN-NVYw^_@{uqSiV }RxvzCMCS De :NCMCSRN10t^Q_uSuqSiTqSiV }4ls^GWf>fNON_fIlxvz0FObVvMR\:ON gsQ|~vxvzDe EecWSfNO(u_fIlxvzDe _bVDe;`~TNNfe0 bVf[_NbSN 0VN:@'`_@{uSuqSivċ0OelT{fċ0O]wQv_Sxvz 0T 0-NV35~64\N_@{uqSiV }NSuqSiKm!jWvMRw'`xvz 0-NNS_@{uBg_2000 3112 893-908 SOS0 5ؚ@Svlu 5.1luvh luؚ@Sv;Nvv/fg'YP^0WMNO_@{SuT{kNv;`qSi0ُ1\Bl;Su(Wluؚ@Sv Te r^`hgQegv@b gS'`qSiV }Y8Tp0ؚƀV@ub|?\u v^S_YtuN TeX[(WvTy4N^`Q0qSiV }Y vQ z^%N͑ ؏|Q g4N^`Q ;N_@{uv~[qSi1\fؚYh5@b:y luُNqSiV }vR^^'Y0 _@{uqSiN@SKNvvsQHTޏ~'` (Wck8^@SVQv^egNOf]_ FOReQ _Sd"80mmHg~v|?\uNv_@{uqSif>fMNO0FEVERxvzfTTMSluOؚ@S` _S4ls^M0R82mmHge RS-NqSif>fMNO0 MSvhnfؚ@S`@SM<140/90mmHg t^{Nb|?\uSu`M<130/80mmHg t^N6e)SM150mmHg YS ؏SۏNekMNO0 ؚqSvuN @SMvh4ls^S[NvQNqSiV }vlu$\vQ͑ Eeh4 c_@{u;`qSi\uNRB\ NFO g)RNQ[NHN7hvuN^_Y~Nbؚ@Slu ؏ gRNnx[uNvMSvhS0Rdkvh@bBlvluR^0 p7 luvhlؚ@SuNvluvh/fg'Y z^vMNOg_@{SuT{kNv;`qSi0ُlu@b g]fnxv SvqSiV } Sb8Tp0@_8^T|?\u (Wluؚ@Sv Te ؏Ttc6Rv^X[4N^`Q0l9hncs gnc bN^nfؚ@SuNv@S6e)ST _S GW^%N30>10>17 5.3^oirlu ^oirluSbc!PeP^u;me_ md N)RN_tTSOeP^vL:NT`N` 0RQ\ؚ@SNSvQ[_@{uvSuqSi wQSOQ[Sb p8 9eUu;me_l9eUu;me_(WNUOeP[NUOuNSb@S:Nck8^ؚf:y sSO NQ\ߘ-NvT NQ͑ Yg\ߘc6R(W;`pϑ25N N P/SkfNONSN dSNDdSؚؚY SN^]ߘˆ}v(yr+R/f|{|ˆ}v(ؚ gsQ gxvzhfkhTT|V!kN NNT|g\vvk Q_uSusQ\280^9eURir'`ߘir~g Q\+Tؚv*s XR+Tˆ}v(ؚ \vy{|S|{|0ˆ}v(`S;`pϑ15]S Rirˆ}v`S;`ˆ}v(200ˆ}v((ϑO!k:NvY0ˆ|0~!0-*s0[r0 iirˆ}v vQ-NF{|g}Y0 5.3.2.3. laeEQT MRFITxvzDehfN@SHTf>fvsQ ُNvsQ(WINTERSALTxvz-N[0FO(WяgTOHPTrials of hypertension prevention ,{N6kSSs g_\\O(u -NVߘNO0NO ^XR+TY+Tؚvߘir Y~S܃ vY F{|6RTI{0 5.3.2.4.YT,܃T4lg xvzfXR,܃b4lgDdeQ Q\DdeQSOSBPTDBP g@b NM0 }ߘkߘ gNOv@S vQMSv\O(uSWN4lg0,܃0ߘir~~TNOv~T\O(u0N{|nߘ^N }ߘ:N;N S_ϑgt`0 5.3.2.5. P6RnR =\{ gxvzhf^8^\ϑnRSQ\Q_uSuvqSi FO/fnRT@S4ls^Sؚ@S`usKNtSHT~'`vsQ 'YϑnRSS_@{NNS\O0Vdk Nc!P(u\ϑnR2Q_u c!Pؚ@S`^bR VnRSXR g(uMSoirvb'`0YnR ^kenRϑ^:N\ϑ 7u'`nR| NǏ30KQ sSaR\N100-150kGS2-3$N bdUR\N250-500kGSJSe-1e b}vR\N25-50kGS0.5-1$N sY'`RQJSϑ U[Y NnR0 Nc!Pnؚ^p'`R0WHO[Rve^/fR \}Y0 5.3.3. XRSOR;mR k*NSRЏRvNyr+R/f-Nt^NTؚ@S`(WЏRMRg}YNN N]vSOrQ NQ[]vЏRy{|0:_^0^Tc~ЏRe0[-Nt^N^Sb g'l08OU\SX:_R~`N N{| wQSOyvS bekL0baэ0*Ygb0t0lRI{0ЏR:_^_{VN _ cyf[;pvBl 8^(uЏR:_^chS(uЏReg'Y_s0R180b170 QSt^ Y50\vNЏR_s:N120-130!k/R YgBl|nxRǑ(ug'Y_sv60-85\O:NЏR[_s (W;S^c[ NۏL0ЏR^N,BlkhT3-5!k k!kc~20-60RsSS S9hncЏRSOrQT@b bvЏRy{|NSlPagNI{ [0 5.3.4. Q{|^ySR Ocs^a_t g|^ySRT_`b/f_wؚ@STvQ[NNba'`uv͑SVKNN [Nؚ@S` ُy|^yr`8^ONN\Ǒ(ueP^vu;me_ YWR08TpI{ v^MNO[bؚ@SluvON'`0[ g|^ySRT_t Ns^avN ^Q{|^ySRT9eS_` cknx[_]0NNT>yO ygSR>yOTƖSO;mR0 5.3.5.vQ[eb [ؚ@S`egbp_N/f͑v }6q<\SNSO@SNǏ'`0WGSؚ FO[MNO govON'`v^XRMSoirvBRϑ0 9hnc N^2lؚ@S^oirceR_~Nh70 h 7 2lؚ@Sv^oirce cevh6e)S NMVQ͑Q\pϑ ߘs^a XRЏR BMIOc 20-24kg/mP2P5-20mmHg Q͑10kgߘPvSeHQ\kNkes^GWߘvϑM8g N TQM6gWSeSc6R(W6gN N02-8mmHgQ\ߘ;`<;`pϑv30 qT<10 X Re,܃ke400-500g 4lg100g {| 50-100g |~{|50gˆ{|khT3-4*N vY{| ke250g keߘl20-25g \T|{|Tu ߘ0XRSO cS_SO R;mRN,khTЏR3-5!k k!kc~20-60R0 YЏRTbaɉo}Y NOct`SO͑ RhfЏRϑTЏRe_T04-9mmHgOcPN‰ _` c ؚ^o RǏ[YeTT cؚNb2uR0 c!P bT*NSOvSO ~;uI{eS;mR XRt^N>yN:gO cؚu;m(ϑ0bp0PR N8Tp; Nc!PnRYnR 7u'`ken R|ϑ NǏ25KQ sSaR\N100-150 kGS2-3$N bdUR\N250-500kGS JSe-1e b}vR\N25-50kGS 0.5-1$N sY'`RQJSϑ U[Y NnR0 Nc!Pnؚ^p'` R0ؚ@SS_@{u`^bR02-4mmHg5.4ؚ@Svoirlu 5.4.1 oirluvh MNO@SOvQ0Rv^uNvvh4ls^ ǏMSluOؚ@SuNv_@{SuT{kN;`qSiMNO0 5.4.2ؚ@SoirluvW@x я40Yt^egMSo NeN b:Nؚ@Sluv;Nce0[TyMSov4N^^(uegyf[vċ0O ;N/f:g4N^Ջ08^N{kT^{k'`_@{NNvSus\O:N~pNNaϑ0(W4N^Ջ-N\NyMSoN[paBRkNNovuHeN[hQ'` bۏL N TMSovkNN N Tluelv6ev0SՋNpeϑ'Y0evՋNf NMۏNekfMSvh^\N140.90mmHg0bVPATSSSRVET\OxvzPROGRESS~ghf MSlu[-NV@{u`N~2 gv Sf>fMNORS-NQSqSi0 NNN:NW@xv:g4N^ՋvNf:y N@SM144/87mmHgvuNvk @SM139/85mmHguۏU\^f>f>eba0FOُy\O(u/fegACEI,g؏/f@SMNO\ NnZi0AASKՋc:yACEI^\tnǏs NMv\O(uONb;nBRbbbBR0Vdk [|?\u` c6R@SN;e } @{'} _ }|~ T7h͑0 eSu|?\u(W4N^Ջ-NOQs|?\ueSuO HOPESCAPPPI{xvzc:yACEI~|?\ueSsNON[paBR~0)R?\BR~bb;nBR~INSIGHTxvzc:ybbBR~NON)R?\BR~LIFEI{xvz:yARBNONb;nBRb8^ĉ~0 ؚ@S-N~pfN@{NN~pvxvz؏N͑ S܏0xvz-N~p\O:Nؚ@S_@{uvKmVP[/fASR_v g)RNSeƋ+RT2_@{uvSu _N g)RN~9(u0 5.4.3 MSoirluSR ] gncfMSoirluSN gHe0WMNO_@{uuvSusT{kNs 2bkRS-N0Q_u0_RpzTuvSuTSU\0MSovqQ T\O(u:NMNO@S N T{|+RMSoS gMSNY\O(uv]+R ُN]+R/f(W N TuN (uoirev;NS0 NS_MRvƋ ؚ@SevMNO@S^ǑSN NSR 1 Ǒ(u\v gHeBRϑN_S gvuHe O NoS^g\ Y gHe Nna S ekXRBRϑN_gsOuHe0 2 :NN gHe0W2bkvhV[_c[ Blk)Y24\eQ@S3z[NvhVQ YdkSN2bkNYNO@S0Rnhf@Sz6qGSؚ s{k0RS-Nb_uS\O00Rdkvv g}YO(uN)YN!k~o gc~24\e\O(uvoir0vQh_KNN/fMS7\k

50 dk{|oir؏SXRluvON'`0 3 :NOMSHegX'Y NXR NoS^ (uNOBRϑUSoluuHe NnavSNǑ(u$NybYyMSoirTTlu0N[ N 2~N Nؚ@S:N0Rvh@S8^MSoTTlu0 h8 ;NMSoir (uv4N^S {|+R^ y_ :_6R'` 0 S)R?\o {VU{| EQ@'`_Rpz  t^ؚ@SUS~6e)g ؚ@SuΘY Z)R?\o )R?\o R NhQ EQ@'` _Rpz)R?\o bV no EQ@'`_Rpz _ hTRpz ؚ @;nBR_~u _hT _ __1Y8^ EQ@'` _Rpz Y Z2-3^?b[ O[ ;n TU ba '`;^X'`u hTV@{ u0| ϑQNO0~ 8^ЏR bbBR N"l!TvU t^ؚ@S hTV @{u Y Z US ~6e)gؚ@S _~u R |7hlxS___ EQ@'`_pbbBR_~u R |7h lxS2-3^?b[ O[ ;n~b^s| 0W\kxSS [ N'`_RǏEQ@'`_Rpz@{'} _ }l bcvb6RBREQ@'`_Rpz _hTY Z ؚ@][R NhQ ^ |?\uuSOR rz1W|?\uu ˆ}v?\@{'} _ }II SSObbBR2W|?\uu ˆ}v?\Y Z ؚ@|?\u_ϑ}vˆ}v ?\ ][S ACEI@b TUSOR rz;nBRMRRzXu ؚ@SOMO'`NO@SEQ@'`_p5.4.4 MSovy{| S_MR8^(uNMSvoir;N gN N5{| sS)R?\o0b;nBR0@{'} _ }lbcvb6RBRACEI 0@{'} _ }IISSO;nBRARB 0bbBR0vMR(WbV8^(uvMSoY N0 h9 MSo S gMSoirk)YBRϑmg ,R g!kpe;N NoS^)R?\o0{VU{|)R?\o@QNO @Q NO @?\xGSؚ S"l/l{VU6.25-251 /l{Vn12.5-251 2TT^ 0.625-2.51 2TT^ʑGr1.51)R?\o@QNO KT{Vs|20-802O)R?\o@Xؚ ?s|m)R5-101-2 (lvvU25-1001-2VnSSOb bBR@XؚQo25-501-2 ;nBR/el{uc _Rb6R nfm\30-902-3 Xbm\50-1001-2 ?fm\12.5-501-2 PNm\5-201 k"}m\2.5-101 -;nBRSOMO'`NO@S /el{uc bm\200-6002 aS~0Wm12.5-502 ?Wm\10-201-2@{'} _ }l bcvb6RBRTU @GSؚ @ {'`4l aSXbnf)R25-1002-3 Onf)R5-402 nf)R5-401-2 Vnf)R5-401 s|nf)R1.25-201 ynf)R10-401 bnf)R2.5-51 WTnf)R4-81 Unf)R10-401 Ynf)R0.5-41 0Wbnf)R15-602 TTnf)R2.5-101@{'} _ }S SObbBR@GSؚ @{'`4l U  /llfW25-1001 ,lfW80-1601 SlfW150-3001NW0WlfW8-321fs|lfW20-801eYlfW20-401bbBRN"l!TvU{|4l 4Yu no~ (l/l0Ws^2.5-101^m0Ws^2.5-201<\aS0Ws^60-902]x0Ws^10-302ʑGr10-202cʑGr30-601<\0Ws^20-602<\"}0Ws^10-401b0Ws^4-61PNaS0Ws^10-201^N"l!TvU{|?b[ O[;n _R b6R ~b^s|90-1803 0W\kxSS90-3603;nBRSOMO'`NO@S YlUU1-161 TUU2-202-3 yrbUU1-201-2-Ng\O(uoir )R@s^0.05-0.251;EQ@ b _R Ǐ mSnuuSPN[0.1-0.82-3NO@SSPN[4Gr0.251/hTvǏOe2uWY]250-10002-3R_c[ MQu1Y "}<\[0.2-0.41GY)R<\[11_` ONRvc@{ib _os|0W\5-1001YkuH\U25-1002ru~T_ؚ@S%`uY l\(uMSoMSoBRϑwHec~ NoS^]xnf0.25-10mg/kg/min IVzsS1-2Rv`_0UTT0 0QWl]xxul5-100ug/min IV2-5R5-10R4Yu0UTTZYbf5-15mg IV1-2R10-30R_RǏ04Yu0no~<\aS0Ws^5-15mg/hr IV5-10R1-4\e_RǏ04Yu0no~~Sm\250-500mg/kg/min IV bolus,dkT50-100ug/kg/min IV 1-2R10-20RNO@S v`_LNb0W\10-50mg IV15R2-8\e4YUf .v`_ u &P0W\kxSS10mg,b5-15mg/kg/min IVNO@S _RǏ N.lU )R@s^0.2-0.4g/!k IV 0.5-1.0mg IMbIV1R 1-2\e1-2\e 4-6\e@|Ǐؚ 4l toYulN NoirBRϑS!kpeNOS [EO(ue gsQoTffN0 5.4.5MSluvV{eu 'YYpeba'`ؚ@SuN^(WQhTQnMNO@Svh4ls^ ُ7h[܏gNNvQNO gv0 cP^(u\O(u6RBR vQ\O(uS24\e ke g(uN!k ُ7hSNQ\@SvlR0MNO;N_@{NNvSuqSiT2lvhV[_c[ v^cؚ(uovON'`0:_g gĉ_vbؚ@Slu 0R gHe0s^3z0gc6RvBl0 9hncW~@S4ls^0 gevhV[_c[TqSiV } (uUSolubTTlu p10 USoluTTTlul'YYpeؚ@SuNFO N/f@b guN ^(WQhTKNQn\@SM vh4ls^0l:NN0RN Nvh 'YRuN g(uNyN NvMSo0l9hncW~@S4ls^NS gev^Su ؚ@S(WwYlueǑ(uNOBRϑv USN(uob$NyoirvNOBRϑTTlu/fTtv0l$NyeHhT g)R _0 (1)USoluwYe(uNOBRϑUSo Y@S Nh XRBRϑ󁳍ϑbbc(uNOBRϑvSNyoir YN NO@Sh R\TNyoir(u󁳍ϑ b9e(uTToirlu0wY(uNOBRϑUSovOp/fSNNuN[TyoirvuHeTS'`vS^ FOe0 (2)TTluwYsSTT^(uNOBRϑ$Nyoir Y@S Nh S\vQ-NoirvBRϑX󁳍ϑ bmRNOBRϑ,{ Nyoir Y@SN Nh \ NyoirvBRϑ gHeBRϑ0TT(uovvv/f ^g goirOS Tlu\O(u vNbm No\O(u V[v Ye6RBR} Nte*N+RoirvBRϑ FOO(ueO, g)RNcؚluON'`0 5.4.6MSluv b MSluv6ev;NegMS,g NT{|MSo(W[hQ'`O NvMSR0 N T{|+RMSodMNO@SY g N TvvQN\O(u0 TN{|oir gvQqQ Tv\O(u sS{|\O(u TN{|ovToirKN\O(u g N T sS*NSO\O(u0[N N TuNoirvuHebS'`O g]+R0ck/foirv N T\O(u:N[ N T4N^`QvuNv (ucONOnc0 N{|;NMSo sS)R?\BR0b;nBR0@{'} _ }lbcvb6RBRACEI 0@{'} _ }SSObbBRARB 0bbBR SN\O:NMSluvwY(uoT~c(uo0 MSov (u^9hnclu[av*NSOrQ oirv\O(u0N"0 NoS^ToirvN\O(u SN NTpZPQQ[0 ~ [a g&T_@{qSiV } ~ [a g&TvhV[_c[0_@{uu0u0|?\u ~ [a g&TSMSoq_TvvQNuu ~ NluvQNv^X[uuvoirKN gevN\O(u ~ (uvoir/f&T gQ\_@{uSusT{kNsvncSvQR^ ~ @b(W0W:SMSoirTyO^NNfGSؚ4OvhV[_c[Yؚ@Su _h{k N3z[_~u 4l _p RS-N }T'`R Q@ ;NR 9YB\ OObTY oirlu0[RvKm@S Sete(uoBRϑ0 p11 MSov blMSluv6ev;NegMS,gl gnchf TN{|+Rv N Ty{|voir\O(u g@b N T [gNyrkSOvu NvuHe_N g]_0loir NoS^ N=\v T *NSO]_f>f0 l)R?\BR0b-;nBR0bbBR0ACEb6RBRT@{'} _ }SSObbBRSNOBRϑ Ye6RBR/fQy;NvMSoir GWSN\O:NMSluvRY(uoT~c(uo0l:_ gyoirۏLMSv‰_]~Ǐe V:N'YYpeuN/f^(u$Ny bfYvoiregO@S0Rvh4ls^v0ls gnchf oirv bS0RYebV }vq_T Sb  uNve_(uo~  oirNv'`0 N T{|MSo(WgNebvSvv[ORN gN \ۏNekvxvz0 5.4.8MSovTT^(u :NNg'Y z^S_luؚ@SvHeg 1\Blf'Y z^MNO@S ZP0RُNpUSolu8^R NS USoX'YBRϑfQs NoS^0:g4N^Ջf 'YYpeؚ@SuN:Nc6R@S{(u$Nyb$NyN NMSo Tv^(uo gvQTNfMNON@{NN0HPS20 000O` 'YY:N@{u ؚ@S`S41 SPROSPER'YY:N@{u 62:Nؚ@S xvz_Nċ0ONuHe0ُNՋvN~Rghf p12 luvsQqSiV }Mol'YYpe gurvQ_u YhTR ub:@'`RS-NuS, 2W|?\uuN Y g;`ƀV>3.5mmol/L (135mg/dl)v ^~NN@l{|Mlu0ll gf>f_@{uubeS|?\u FO10t^_@{0OKmqSie"20vuN Yg;`ƀV>3.5 mmol/Lv _N^S_cSN@l{|oirlu0b@\glul g_@{NNe_SvuN^S_cSb@\glu V:N gnchfb@\ gluyr+R/f\BRϑ?S9Sglu SNMNORS-NT_h{kvqSi0l\BRϑ?S9Sg[50\N N @nP-N^GSؚb10t^;`_@{qSie"20 vؚ@SuN gv0lS g(W@Sc6Ro}YeMb~N?S9Sg0ؚ@Sb^ؚ@Slu[2Q NNvHeg/fv115mmol/L`v_@{NNT_h{k>fWQ\0gя[bv-NV_xvz-a!CCS-2 :gluN46000O%`'`_h{k` ~ghf/l!TfMNONN~~pNN0 [ؚ@S4O:@'`@{ub_@{ؚqSV }@Sc6RTS~N\BRϑ?S9Sg0 5.6.3@|c6R ؚNck8^vzzy@|f FOtSf>fQNO_@{v^Su0lu|?\uvt`vh/fzzy@|d"6.1mmol/LbHbA1cd"6.50 5.7 luʋSU_ 5.7.1ʋvvvSQ[uN_YluTvNke :NNċ0OluS^ O@S3z[0W~cNvh4ls^{R:_ʋ ʋƉvvew0 ʋ-Nd[RvKm@SSuNvvQNqSiV }T4N^`Qv9eSNS‰[uHeY ؏NuN^zo}YvsQ| TuNۏL[Ye uNN]vu` Sbؚ@S0qSiV }S TeX[(Wv4N^`Q N㉧c6R@Sv͑'` N~uluv_'`0 :NNSoirluS_nauHe ʋe^:_ ce go uNNyoirluSQsvoR\O(u TNeQs ^SebJT meQEmQ0W_TuNʑ9eSu;me_v͑'` OKNtvQluaIN ɉ0WN[ gZWc0 ʋ9hncuNv;`qSiRB\S@S4ls^ 1u;SuƉwQSO`Q [ V20 uN@SGSؚN^\ck8^ؚfoR\O(uؚqSS_ؚqS-NqSSNOqS10XR!kpe 20傻luTeS ^ 9e(uSN{|o irbR(u\BRϑv SN{|oir 30 gRS^ SX'YBRϑ0bR (uNySN{|oir b9e(u\BRϑTv^ (uo 40fRygw0W 9eUu;me_109e(uSN{| oirbvQN{| oirvTv^lu 20Q\BRϑ 10k1g ʋN!k 20vKm@ST yqSiV } 30:_STy 9eUu;me _vce10k3*Ng ʋN!k 20vKm@S SqSiV } 30:_STy9eUu;me_vceYtluvؚ@Sl0Rؚ@SNyʋ Qoؚ@SuNN,{~lu0uN~nxʋ:Nؚ@STL\Po vQ@Sbߏbe ~\V Y0RluMR4ls^0FOuNv@Sgc6R SNՋV\_0ek0WQ\ gopebBRϑ0$\vQ/fw0WۏL^oirlu [R0W‰[9eۏu;me_ۏ^THegvuN0uN(WՋLُy ekQo e ^ASRN~0WvKm@S0 U_N,ؚ@SuNvluepeASt^ lueHhO gY!kSbc Sboirv b0g}Y^uN~U_vQ(uǏvluoirSuHe0;SuRf^:N~KbluvuNOX[EQRvU_ eY(u0 ؚ@Sʋ@SNuN1\ʋeʋ;SuKmϑv@SNO  YeSs@SGSؚ R~uN͑ YKmϑ Y^ Te N!k@SGW&{Tؚ@SʋehQRʋ:Nؚ@S0 YN_ʋe:NSS'`ؚ@S ck(W(uMSluv,g!kKmϑ@S<140/90mmHg RʋeQ:NSS'`ؚ@S(](uMSolu)0 Y,g!kKmϑN!k@Ss^GW60\0 'Yϑ:gS4N^ՋGW[e/f6e)/ _gؚ@S ؏/fUS~6e)gؚ@SMSlu[t^`GWSQ\_@{uS{kN0ncSHEP0Syst-Eur, Syst-ChinaI{US~6e)gؚ@S4N^Ջv~TRg MSluSORS-NNN NM33 Q_uNN NM230 6.1.2t^NMSluv(uo 'Yϑ:gS4N^ՋGW]fnx Tt^k<80\ ؚ@SuNGWSvN)R?\BR0bbBR0b-;nBR0ACEI-II{bؚ@Slu0STONExvz^(uv/fVNv]x0Ws^GrBR Syst-ChinaxvzR^(uVNv<\0Ws^ ُNo gHeN Nf50 6.1.3sQNؚNvMSlu s gv'Yĉ!j4N^Ջ@b‰[vt^uN ؚuNv^ NY0STOP-ITSTOP-a!eQ uNvt^:N7084\ FO80\N N NY0HYVET@bxvz:N>80\ ^(uvoir:N2TT^ʑGr1.5mg/d SWTnf)R vMRxvzck(WۏL0\ONvcDefMNO@S[ؚNvq_T N Tv@S4ls^[NNvTaINN*gfN ؚNۏLMSlu/f&T T7h_vbؚ@Slu[ؚNvaINYUO\_xvz0 p13 t^NvMSlul:g[gqՋ[ e/f6e)T _gؚ@S ؏/fUS~6e)gؚ@S MSlu[t^uNQ\_@{uuSuT{kN/f gvv0lt^uNvRYMSlu^u_N,SR FO^ekMS $\vQ(WSO( 1_vuN-N0l^KmϑvzMO@S NcdSOMO'`NO@S v^ċ0OMSluvSOMOHe^0lYuNX[(WvQ[qSiV }0vhV[_c[Sv^X[_@{`Q [ُ{|uN luoirv b^8^Na͑0lYt^uN$NybfYoirc6R@S 1uNt^N@SMNO^ 'Y Eet^Nv6e)Svh:NM150mmHgN N YS ؏SۏN ekMNO0l80\N NvuNMSluvHeg\_ċ0O06.2 Y Zؚ@S 6.2.1Y Zؚ@S~T_Pregnancy lnduced Hypetension, PIH 6.2.1.1[INY Z20hTT U[YSuؚ@S ˆ}v?\S4ly:NY Zؚ@S~T_0 ؚ@S@SGSؚe"140/90mmHg b@SU[MRbU[eg@SGSؚe"25/15mmHg \N!k 6\e0 ˆ}v?\US!k?\ˆ}vhge"30mg \N!k 6\e b24\e?\ˆ}v[ϑe"0.3KQ0 4lSO͑XR>0.5kg/hT:N'`4l0 c4lv%N͑ z^SR:N+ @\PS\ ++ 4l^S'Y +++ 4l^SO4Sy0 Y Zؚ@SN gؚ@S 4Ob N4O g4l N4O gˆ}v?\0 HQFQP[u/fY|~S/}v`Q ;Nv/fkSO_8^SuN00SQ@|~ 1uN΀v@AmQ\S_w΀?Quߏb΀{k[Q0 {^HQFQP[u gؚ@Sv^4O gˆ}v?\vX[(W0 ͑^HQFQP[u@Se"160/110mmHgˆ}v?\e"3KQ/24\e4O g4Yu Ɖir Nn v`_ UTT S Nyuu37hT Se~bkY Z ΀<35hTO΀bqT ~bkY Z0 ~bkY Zve_SQNNyv`Q0 6.2.2MSov^(u }6qluؚ@Svv/f:NNQ\kNvqSi FO_{ b[΀?Q[hQv gHeoir0 S_@SGSؚ>170/110mmHge ygMS N2-NΘSP[uSu0vzz@SMYNOT vMR\eNva0 6.2.2.18^(uN'}%`MSvoir ]x0Ws^Nifedipine 10mgS g 60RT_eQ~o0 bm\Labetolol 25-100mgReQ5a|20-24ml Y cl015RTS͑ Y0 UHydralazine 5mgR5a|20mlY bacl k5RKm@SN!k 20RT @SN>160/110mmHg S͑ Y~o5-10mg0 _S90mmHgbN NR\Po0 6.2.2.28^(ubaMSvoir 'l ^m\ Oxprenolol :20-40mg, ke3!k S_w_RǏ ?fm\Atenolol 100mg 1!k/e gO(ub-SSO;eBR g_w΀?QuߏvS0 2uWY]Methyldopa 0.25-0.5g 3!k/e UHydralazine S g25-50mg 3!k/es] NcPY l\U 0 Ob0Ws^Isradipine 2.5mg 2!k/e labbBR NNkxxAT(u \o(WvOS T\O(uS[NO@S 0 6.2.2.3U[g N[O(uvMSo ACE-IS_w΀?Quߏ 4lǏ\ beu?Qp NS_w΀?Qxub_0 @{'} _ }a!SSObbBRATB1BSSObbBR oR\O(u T N0 )R?\BRSۏNekQ\@[ϑ O΀?Q:'lR͑0HQFQP[uYsY@[ϑQ\ d^X[(W\?\`Q &TR N[O(u)R?\BR0 6.2.2.4Y Zؚ@S~T_vT ΀?QSSu[Quߏ ΀{k[Q QueSueu?Qzo`U[NYSSu΀vegeRy[%_+o'`@{QQ@S/b%`'`Rpz_p04lHELLP~T_n@'`+@ vGSؚ @\gQ\ S NQ@ 4xˆ P[ubdTSu@ Q@Su u_wU[NY{kN0 6.3@{u @{uSbRS-NTNǏ'`:@S\OTIA 0 gxvzc:y@S4ls^NRS-NQSu gsQ0RS-N`-Nؚ@S`S50-600RS-Nt^ YSs~40c6Rؚ@S/fRS-NN~2vsQ.0 bVgxvzc:y @{u`W@xSluT@S4ls^NRS-NQS gsQ0@S4ls^ؚRS-NQSsؚ0яt^egShv'Yĉ!j:g4N^ՋhfMSlu[e_ g@{uuS`v4N^vY0-NVPATSxvzeQ 5665O gTIASb*gWYu%N͑kuRS-NT` :g(u)R?\BR2TT^b[paBRlu3t^ ~gO@S]+R5/2mmHg ;`RS-NSuv[qSi NM29P<0.001 SNyVEY-N_ՋPROGRESSxvzeQ gfnxRS-NbTIAS`6105O :g(uWTnf)RbR2TT^ b[paBRlu4t^ ~gORS-NSuqSiQ\28P<0.0001 0;`@{NNSuQ\26 N~Rgc:yMSlu[4Oؚ@Sb^ؚ@Sv@{u`GW gv@'`b:@'`RS-NuS_NGW gv0vQ-N-NV1520O` 6t^hf MSlu[-NV@{u`vvYf'Y NNf>fMNORS-NSuqSi N_NQ\N;`{kNqSi0s gvnchf 2TT^bWTnf)RR2TT^glu@{u`/f gvv SQ\RS-NQSqSi0 %`'`RS-N/f&TǑ(uMSlu @S^MNHN z^ NSǑSNHNce NۏNekv'YW:g4N^xvzRNċ0O.0SS-NV@{u2lcWS0 6.4Q_u Q_u`Q!kSu@{NNvqSigؚ NNGWN@S gvcsQ|0|Q`Q_uNؚ@Sv`cSMSluvDe gP FOY8^(uvMSof^l^(uNTy N T`QvQ_uN }6qv^^(uNMNO@S0(WُNoir-N -;nBR ACE-ITVnbbBR(W%`'`_h{kTT_Rpz`-N[fnx2_@{NN ^[}T0FOُyHeg(WY'Y z^ Neg@Sv NMv^ NASRnZi0ISIS-4 CCS-1 GISSI-3I{'YW4N^ՋGWhfACEIeglu%`'`_h{k`/f gvv0EUROPAՋhf3z['`Q_u`(W8^ĉluW@x N WTnf)Rk[paBR~>fWMNONN~~pNN FOPEACEՋRl gSsYnf)RvvY0 -;nBR(W4N^Ջ-NQ\%`'`_h{kuNQh{kS_@{{kN~1/4 0CCS-2ՋhfXbm\eglu%`'`_h{kuN f>fQ\NQh{kS[ FOXRNOKQ0-;nBR(Wba'`EQ@'`_p`-NQ\;`{kNsTs{k0Qy'Yĉ!jv4N^Ջ[ ACE-I(uN_pb][R NouN _h{kbs{kqSiQ\~1/50HOPEՋ-N'YYpe`80 gQ_u N[gq~k O(uACEIluSf>fMNO_@{NNT{kN04N^ՋS f[N[Q_NNvQ\fWGSؚ0dked c%`'`_Rpzv8^ĉۏLYtY =\_MNO@S__ASRsQ.0O(uY @{ib _BR__0RnavHeg0 6.6ؚ@STv^|?\u |?\u8^Tv^ؚ@S bVؚ@S(W|?\uN-Nv`us'Y~/f40-551994t^hQV22NNg:N55 3NNg:N38 NSV[40-60 vf:y 6e)Sk NM10mmHg |?\uvsQvNUOv^Su0{kN0_h^X0_@{v^SuGWSN NM10N NM@Slu[_@{vvY}YN['Y@{v^Su0 gxvzhfMSluSNQ\|?\uv_@{Θi74Y~'YWxvz؏[|?\uNvM@SluHegON^|?\u0 6..6.1|?\uvhgNʋe |?\u[{gTʋ{8^ĉhg@S nxʋv|?\u`^k3*Nghg@SN!k NSeSsNuv^SYgSs@Se"130/80mmHg ^e YgN8h[@SGSؚ Tela^y~uS[vSOMO'`NO@S0[]ʋeؚ@Sv` ^khThg@SN!k NnxOh0(Wʋeؚ@Sv Te\ۏL'Y@{T_@{v^Suvċ0O0_@{v^SuhgSbf:y 1W|?\uuN8^ĉTT^(uACEb6RBR02W|?\uu N8^ĉTT^(u@{'} _ }SSObbBRGWwQ gOb\O(u0l[@SYNck8^ؚe[ YN140/90mmHg:Nluvh NMQ@SM_whVO@ N0 ADVANCE:NMSNM|lu4O_@{qSiV }v2W|?\u`N2@{uuvxvz g2007t^[b0J\e\ScO|?\u2@{NNvfYnc0 6.7ba'`uu p15 R NhQuNvMSlu1 (WMSoNNMR SS'`ؚ@SuN_c[/f_8^v0l|?\uOb g$N*NHQQagN  %N1g/)Ye @S^<125/75mmHg   =\S\?\ˆ}vMck8^0l:NQ\ˆ}v?\ 8^^(uACEIb@{'} _ }SSObbBR0l:NO@Sh 8^TT(uoXRNy)R?\BR 0l:NN2b^R lxS ;e } @{'} _ }|~/f͑v;`KN [@b gRQ vؚ@SuN:_SMSlu^S_(Na0ba'`uuv[IN:Nt$ GFR<60ml/min/1.73mP2PT/bu$_ϑˆ}v?\0?\l#n_8^T/bv$q_af[hgbuthg_8^0/f@Sv͑hV[ TeS/fؚ@S_c[v;NvhV[KNN0ؚ@SNe[ b_c[ SSNV[SOms^aNS@{;m'`ir(I{N"x RgRNؚ@Sv%N͑ z^ b_c[Nؚ@SKNvv`'`_s v^ۏNek[_@{u0SS'`ؚ@SSN[􁾀\R lxS R_c[SNeb(WTySSb~S'`[('`uu-N SbTy\tp |?\uu ~erup0h;'`uI{ Qs'`ؚ@SS80-90 /f~S'`ؚ@Sv;NSV0@wR_c[R͑ ؚ@SvQss0%N͑ z^Tl z^_NR͑0eUOyuV@bv_c[ c6Rؚ@S[N2bkuSvc~ۏU\T~Sv_@{Tv^uwASRsQ.v\O(u0Vdk (W4N^]\O-N_{la[ؚ@SuN[gJSt^bNt^ hgRS?\8^ĉ [uN^(Wk!k1\ʋe g@SU_08^O(uvRhgSb@?\ }.l P4ls^vKm[ N,S(W_c[%N͑ee_0RS f ?\8^ĉhg-Nˆ}v?\vQs__eg>f:y_c[vX[(W ?\_ϑ}vˆ}vKm[RShgQfev_c[0 uuSb|?\uu ^%N1g/de @Svh^<125/75mmHgv^=\S\?\ˆ}vMck8^0N,(uNyN N u NyoireO@Sc6Rh ACEI/ARB 8^NbbBR0\BRϑ)R?\BR0b-SSO;nBRTT^(u0S_@P>2mg/dle cP(u)R?\BR0^nXR(uoTyTBRϑ MQO@SǏ%`0W NM Tela‰[(W@S NMeRvSS0(W TI{MNO@SvMRc NTy N TMSoir[^uSvۏU\q_TS[hQNFO gNNxvzc:yO(uACE-IT/bARB[ˆ}v?\vQ\NS^uSvۏU\ g)R0 6.8l'`ؚ@S 6.8.1[IN(W^(u9eUu;me_T\3ybؚ@Soluvcec~3*NgN N ,N N\6e)ST _Sc6R(Wvh4ls^e y:Nl'`ؚ@Sb}V'`ؚ@S 0 6.8.2 l'`ؚ@SvSV SvSVSb*ggQv~SSVMSluON'`]N(W^(uGSSoS gU[o Nz{|V{|0SaSV0uI0ĞI{ 9eUu;me_1Y%SO͑XR ͑^nR [ϑwǏ͑)R?\BRlu p16 l'`ؚ@SvSVl*g[ɉv~SSVlluON'`]lN(W^(uGS@Soirl9eUu;me_1Y%  SO͑XR  ͑^nRl[ϑwǏ͑  )R?\BRlu NEQR  ۏU\'`R NhQ  ؚvDdeQGP'`lu'`ؚ@SvSVlUS~'`ʋ@b}v'Yc ؚ@SluN󀊁|e*gO(u'Yv&^ NEQR ۏU\'`R NhQ ؚvDdeQ 0GP'`l'`ؚ@SvSV8^:NUS~'`ʋ@b}v'Yc ؚ@SKmSel guN N|e*gO(u'Yv&^ 0 6.8.3 YtSR ~bQSVYtT NeHege WB\;Su^bl'`ؚ@SuNlؚ@SNyۏLlu0(W@b gRR1Y%T (WۏL%N[‰[ N\P(us gMSo ͑e_Y^(uNyev{USvlueHhS gRNSb4xُyv`'`_s0 6.9  N"~T_  N"~T_ /fc(W*NSO-NYyN"_8^`QƖ~X[(Wvsa ُN_8^Sbր @ul NoGSؚ HDL-CNO N @SGSؚ @|_8^ _ϑ}vˆ}v?\ ؚ?\x@uI{02004t^lQ^v-NNS;Sf[O|?\uRO^ N"~T_ vʋehQ&{TN N4*N~bbR-Nv3*NbhQ t$ ͑bրSO͑cpee"25.0kg/mP2P0 u$ ؚ@|zzy@|e"110mg/dl6.1mmol/L S/b|w2h@|e"140mg/dl7.8mmol/L S/b]nxʋ:N|?\uv^lu0 v$ ؚ@S6e)S/ _Se"140/90mmHg S/b]nxʋ:Nؚ@Sv^lu0 w$ @ }qNzzy@ul Noe"150mg/dl1.70mmol/L S/bzzy@HDL-C7u'`<35mg/dl0.9mmol/L sY'`<39mg/dl1.0mmol/L 0-NNS|?\uBg_ 2004t^,{12wS3g @wbVE\lu;me_vSS  N"~T_ `usHTXR0 Nwm>y:SN N"~T_ `u s:N17.30 N"~T_ XRN|?\uT_@{uSuvqSi0  N"~T_ v4N^Yt;N/f9eS Nou;me_0͑bրQ{SO͑S_XRSOR;mRS_Q\DdeQϑ_e@S@|0ygv9eUu;me_ gRN N"~T_ gsQbRv9eU g)RN2|?\uT_@{uvSu0 6.10 ؚ@SqSa ؚ@SqSaSbؚ@S%`uTؚ@SN%`uؚ@S%`u(Hypertensive emergencies)vyrp/f@S%N͑GSؚBP>180/120mmHg v^4OSۏL'`vhV[R NhQvhs0ؚ@S%`uzsSۏLMSluN;bkvhV[ۏNek_c[0ؚ@S%`uSbؚ@Su0QQ@0%`'`_h{k0%`'`][pz4O4l0 N3z['`_~u0;NR 9YB\R $v0 ؚ@SN%`uHypertensive urgencies /fؚ@S%N͑GSؚFO N4OvhV[_c[0 ؚ@SqSavYt ؚ@S%`uُ{|uN^ۏeQR:_vb[ c~vKm@ST=\_^(uTvMSo0 MSvh/fY lMSo 1\eOs^GWR @Sŏ NMFO NǏ25 (WNTv2~6hQ@SM~160/100-110mmHg0@SǏ^MNOS_w bQ :@0Ygُ7hv@S4ls^SSvT4N^`Q3z[ (WNT24~48hekMNO@S0Rck8^4ls^0 NR`Q^dY%`'`:@'`RS-N  l gfnx4N^ՋncBlzsSbؚ@Slu;NR 9YB\^\SBPŏM100mmHg]SYS 0 gNؚ@S%`u`(uS gwHeMSoS gv YaSXbnf)R0bm\0SPN[0 %`u8^(uMSo g]xnfY <\aS0Ws^0LNb0W\0N.lU U0bm\0~Sm\0ZYbfI{0 7. ؚ@S2lv[V{ ؚ@Se/fNy(WbVWaNnfMAmLvuu _N/fNySN gHec6Rvuu 傤Ƌ0RMO ce_S_ NFOSN gHec6R@S4ls^ NSNQ\`RS-N0Q_u0RpzTyOTSU\0 20N~50t^N bVؚ@S2l]\Of~jȏ0WcQ ؚ@SNO4Y Wav/fُNt^eg ؚ@S`ustS(WHT Ne NGSR0 bؚ@SAmLvSV/fYyY7hv vQ-N NON>yO0~Nm0sX0NSI{V }0FO/f NvYNNO4ls^vNؚ@SwSfs0 gosTc6Rseu/fN*N NS_Ɖv͑SV0Vdk RRc6R@S cؚ Ns 4ls^^/fbVؚ@S2lv͑NR0 ~‰VQYؚ@S2lvS zN~ ؚ@S2l_{ǑShQN0ؚqSNTuNv~Tv2lV{eu Nc6RqSiV }4ls^0eʋelTuNvĉS{t N*NseQKb gQ{ؚ@S2lvhQbb~ N Nvhv[s_{O`‰_vlSTbeuvly ;Nhs(WN NQ*Neb (1) NNuu:N;N[ lTNeP^:N;N[ NRQSp^NOeP^:Nvv NNN/fc6Ruu0 (2) NN`:N-N_ lTNN:N-N_ \]\Ov͑_MRy nfMcؚNvOePaƋTeP ^4ls^0 (3) NN;Su:N͑p lTN2OeP:N͑p ~TltTyqSiV } c6RteSOqSiV }4l s^0 (4) NNNy;Su:N;N lT;Su0bX0h0lQqQkSuI{NXTqQ TSNvV{t0 (5) NN'Y;Sb:N-N_ lTN>y:S:N-N_ \ؚ@S2lv?eV{0ce0bgT~Sb>y :S[0 (6) N͑Ɖuuv2ll:NsQl_eP^SNsXvOS~N SOsNN:N,g OۏNN6q T0 (7) NkSulT>yOqQ TSN EQRS%c?e^Tv^0NNVSO0ON0eZNS >yOTLuv\O(u ^z^lvؚ@S2lTvT~Nb~0 8.ؚ@Sv>y:S2l 1uNuu!j_vlS ؚ@Sv2lV{eu1uUS~vuirf[2l!j_lTSb>yO0_t(WQv~T2l!j_ Vdk>y:S_U\ؚ@S2l/fc6Rؚ@SevXRvsQ.0bV>y:SkSu gRv_U\N>y:SRv Ne[U:Nؚ@Sv2lcON͑v:gG0 >y:Sؚ@S2lЏ(ueP^Oۏvt\hQNV{euTؚqSNV{euv~T N~20N~2N N~2v~T _U\NSOSv~T2l0 8.1>y:SSN NsX[vkSuOePQ:NW@x YOS\O RXThQ>y:SSN>y:Sؚ@S2lvR [eTċNhQǏ z0 8.2 ?eV{SU\NsX/ec (Wc!PeP^u;me_eb0Oۏؚ@SveghQTluebSU\?eV{TR /ec'`vsX0 8.3eP^Ye ؚ@SveP^Ye1\/f9hnceS0~Nm0sXT0Wtv]_ [ N TvvhNǑ(uYyb__ۏLOo`v Od lQOYe^@w͑N[ Oؚ@Svyrp0SVTv^Suv gsQwƋS2'`TSlu'` NSu;me_(Wؚ@Sv2Tlu-Nv\O(u0 8.3.1>y:Sؚ@S2l[ O WB\;Su^NSS_0W[v/ecTMT [>y:SN,N_U\ؚ@S2lv[ OTYe0[ Ovb__SY7h0 u~~eP^YeOPN0 u[g>NReP^^ u[ Ohbўgb u0We^d5uSb5uƉS ueW[[ OPge 8.3.2.ʋuNYe (1) uNYeV{eu lYeʋe - nx[uNvvMRL:NrQ - nx[uNvwƋ0b4ls^Tf[`NR - nx[uN`^TO_ - nx[яgQuNHQǑS9eSv Tc[ - c[wQSOS - L:N9eSN\ϑ_Y YebvSNN/ec NTeb~uNc~vNvckbveP^Oo`SR:_uNL:Nv9eS0R:_ - [^T gSvSNhQSO;SRNXTvSN - uNSN lNċN [guN SeċNTS v^~~[ NNekvvh SOuN9eSvL:N]VTc~ NS0 (.2).eP^YeQ[ ^[ N TN_U\ N TQ[veP^Ye0 h10 N TNeP^YeQ[ ck8^Nؚ@SvؚqSN]nxʋvؚ@S`lNHN/fؚ@S ؚ @SvqS[ eP^ u;me_ [gv vKm@S0 lؚ@SvqSiV } g[ '`vL:N~ckTu;me_c[0 l@SqSiRB\ vi_TaIN l^oirluN gv ͑'`TZWc~ luv_'`0 lؚ@S/fSN luv ck nxƋؚ@So irvuHeToR\O(ulؚ@SvqSiV } g ['`vL:N~ckTu;me _c[lNHN/fؚ@S ؚ@SvqS[ eP ^u;me_ [g vKm@S0 lؚ@SvqSiV } g[ '`vL:N~ckTu;me_c[0 l@SqSiRB\ vi_TaIN l^oirluN gv ͑'`TZWc~ luv_'`0 lؚ@S/fSN luv ck nxƋؚ@So irvuHeToR\O(u 8.4 >y:SkSu gR͑e[MO SU\>y:SkSu gR:Nؚ@Sv2lcONo}YvQY:g0>y:SkSu gR͑e[MO^R:_N NQ*Neb l;SuN2Dё͑eRM R:_2DёvkO l\ؚ@S2lv8hchReQ>y:SkSu gR8^ĉ8hSO|-N l;SuOi^/ec>y:SkSu gRvSU\ oRؚ(ϑNOb,gv;SuOeP gR lWB\;SbN N~;Sb^^zEu0N)RvSTlʋ nSTЏL:g6R >y:STT~;Sb^SU\ؚ@S2lv4N^_ ǏĉS{tcؚ;SuOeP(ϑ0 8.5W ;SuTvQNkSu]\O_{~8^_0R_}YvW Sb;Sf[b!hvYeT(WL~~W yr+RR:_WB\hQy;SuTkSuOePNXTvW Ncؚ[ؚ@S`vhQ02c[Tlu4ls^0 8.6:W@br^ ؚ@Svr^V{eu_{=[0R:W@b-NMb[s eP^Oۏv:W@bR:NN{|1 .hQ^2 .;Sb 3 .E\l>y:S 4 .]\O:W@b 5 .f[!h09hnc N T:W@bvyrp cgq%n*YNS[zvSR6R[T[er^R0 8.7.vKmTċ0O ċN/fr^v͑~bR /zNr^vY~0vQvv/fǏvKm~gċNr^;mRvۏU\`QTHeg ۏLOo`S NSeteR 0Rgvh0vKmRSSbN NQ[ 1 L:NqSiV }vKm SċNvhNvwƋ `^TL:NvSS`Q 2 . NesXvKm SċN?eV{T>y:SsXV }v9eS 3  {kNvKm SċNvhNvuu{kNsvSS 9 cWSv[e 9.1?e^TkSu(Wc6Rؚ@Suu-Nv\O(u ?e^[ؚ@Sv2c6RwsQ.\O(u kSu]\ؚ@Sv2lReQ]\O z v^yg0W/ecTcRؚ@S2l]\O0(WN NQebw;N[\O(u 9.1.1.6R[2Tc6RbVؚ@SvhQV'`V{eu0 9.1.2.6R[SSU\ gvNؚ@Sc6RvlQqQkSu?eV{ 6R[?eV{vSR l2bk?QzTRt^-NQsؚ@SqSieP^Ye^Sb?QzS[0 lc!P gvN2ؚ@Svnߘ`N` OۏߘT]NuNNOv0NOvߘT0 ߘT%{Qh~{?eV{ߘTlfTvv+Tϑ 0 QN?eV{YOe4lgT,܃ 9eSRir'`ߘT~gI{ 0 lOۏ_U\ gĉ_vSO;pcOSO;mRv:W@bTagN0 lcp?eV{0 lOۏؚ@SeghQ?eV{;Sbʋ:NTuN8^ĉKmϑ@S6R^ \egʋeTluؚ@SeQkSu gR-N0 l oir?eV{RuNN^ gHev bؚ@Soir0 9.1.3Oؚ@S2lv~90 9.1.4/ecTW[ؚ@S2Tluvxvz0 9.1.5cwOhQVTw^c^[e 0-NVؚ@S2lcWS 00 9. 2 f[/gVSO(Wc^cWS[e-Nv\O(u f[O0OSO0ؚ@STvI{f[/gVSO^S%cOR ~~NNNg[cWSvBlT[e`QۏLċN (uTy Ode_[ O-NVؚ@S20hQ0ċNTlucWScQؚ@Sv2lbeu(WhQV^zOo`T~Q 6eƖT Odؚ@S2lvOo`Oۏؚ@SWvf[/gNAm0 (WT0W:SW,gVSObXT NOۏ[cWSvt㉌T[e _U\ gsQcWS[evBlċ0OT[eċNvg cO gNy:Sؚ@S2lR_U\ؚ@SSNؚ@S gsQveP^Ye0 Q[ 9.3.1;SRNXTvYe l 0-NVؚ@S2lcWS 0 ThQVv;SRNXTQy;Su0ؚ@S2lvWB\;SRNXT cOcWSUSL,g gsQf[/gVSO^#0We;SuvW]\O0 lbVؚ@SvAmL`Q hQV N!kؚ@SAmLuf[g~g Sbؚ@SvAmLR0t^'`+RR^00WtR^0ؚ@SqSiV }0ؚ@SuN go`QI{0 l[ؚ@SuNv{wr^p:_ؚ@SuNu;me_c[\O:NluvW@x Oۏؚ@SuNvʋTZWclu0 lؚ@Svoirlu0 9.3.2 lQOYe l Od nS\QP[0[ O;u05uƉ0b~I{'YOZN ^ b[bvNE Od0 lo`ؚ@S/f8^v FOSc6Rvuubt^Nkt^\Kmϑ@SN!kրTvDdeQǏY/fSuؚ@Sv͑qSiV }ؚ@SvʋehQ0 lQ[YUO2ؚ@STRS-NSvQlu ؚ@SvN~20 9.3.3 uNYe lؚ@SuNYUO9eSu;me_ Ttߘ0bpPR0S_ЏR0d|^y'} _0c6RSO͑ l`ؚ@ST`HNR lgN~lu0 9.4 NS>yOTLuv/ecN/{_[ecWS :NNcWSv/{_[e S%cTLuvRϑ NS~9 N0?eV{ NTsX Nv/ec0 9.5 ^zhQV'`TVE'`OS\OsQ| ^(WkSu萆[ N kSu_@{u2lxvz-N_~~OShQVTw^ꁻl:S gR0W[Tc^cWS0 -NVؚ@STvR:_NVEؚ@STvI{VEf[/gVSOvf[/gT| NcOb/g/ec0-NVؚ@STv~~~~ؚ@S]VbJT [ؚ@SecWS0 9.6 vc 0-NVؚ@S2lcWS 0v[e )R(u] gvOo`|~bǏyrkvg Nvcؚ@SSvQqSiV } NObُNqSiV }Xv>yO~NmagNvSS`Q NS 0-NVؚ@S2lcWS 0[ev`QTHeg0 10. T ~hQVя~vMON[Y!kx NASYMON[Od (WS YY!k^l_BlaW@x N 2005-NVؚ@ScWShQeHr[bv^lQ^0FON g k: Ne[U0vMR ;NNR/fygc^cWS 'YR[ OcWS hQ>yO͑Ɖؚ@Sv2l0RRcؚbVؚ@SvwSfs0lusTc6Rs0c!PbNkt^\KmϑN!k@Sؚ@S`^gĉ_lu w9eS Nou;me_0c6Rؚ@SS gsQqSiV } O6R_@{uXvR0 ~_g [?zeg 2005t^10g Se.s( cShec^) 1. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenes of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA, 1986,26:2823-2828. 2.Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet,1990,335:827-839. 3.SHEP Collaborative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP).JAMA,1991,265:3255-3264. 4.Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S). Lancet,1994,344:1383-1389. 5.PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl), 1995,108:710-717. 6.Gong LS, Zhang WH, Zhu YJ, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens, 1996,14:1237-1245. 7.Staessen JA, Fagard R, Thijs L, et al. for the Syst-EUR Collaborative Group. Systolic Hypertension in comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet,1997,350:757-764. 8.Agabiti Rosei E, Dal Palu C, Leonetti G, et al for the VHAS investigators. Clinical results of the Verapamil in Hypertension and Atherosclerosis Study. J Hypetertens,1997,15:1337-1344. 9.-NV_xvzOS\O~RRu se v[m .aSXbnf)R[%`'`_h^X`egu{kNsTv^Suq_TvY-N_4N^Ջ  14962O;`~. -NNS_@{uBg_,1997,54 245-251. 10. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39.BMJ, 1998,317:713-720. 11.Liu LS, Wang JG,Gong LS,et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens,1998,16(12 Pt 1):1823-1829. 12.The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID)Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med,1998,339:1349-1357. 13.Liu LS, Wang JL, Gong L, et al for the Syst-China Collaborative Group. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens,1998,16:1823-1829. 14.Franklin S, Khan SA, Wong DA, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation,1999, 100:354-360. 15.Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive dugs in elderly patients: cardiovascular mortality and morbidity in the Swedish Trial In Old Patients with Hypertension-2 study. Lancet,1999,354:1751-1756. 16.Xiang-Hua Fang, Richard A, Shi-Chuo Li, et al. Prevention of Stroke in Urban China A Community-Based Intervention Trial. Stroke. 1999;30:495-501. 17. Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:the Captopril Prevention Project(CAPPP) randomised trial. Lancet, 1999,353:611-616. 18.The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin- converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med,2000,342:145-153. 19. Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the international Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet,2000,356:366-372. 20.Hansson L, Hedner T, Lund-Johansen P, et al. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem(NORDIL) study. Lancet,2000,356:359-364. 21.Adler AL, Stratton IM, Nei HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36):prospective observational study. BMJ,2000, 321:412-429. 22.Gosse P, Sheridan DJ, Zannad F,et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg; the LIVE study. J Hypertens,2000,18:1465-1475. 23. se RRu v[m, I{. bV'Y7h,g_@{u4N^ՋvV~NU\g. -NNS_@{uBg_,2000,285 335-338. 24.Ruilope LM, Salvetti A, Jamerson K, et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol,2001,12:218-225. 25.Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Executive Summary of The Third Report of The National Cholesterol Education Program(NCEP)JAMA,2001,285:2486-2497. 26. PROGRESS Collaborative Study Group. Randomised trial of perindopril based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet,2001,358:1033-1041. 27.Terpstra WL, May JF, Smit AJ, et al. Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial. J Hypertens,2001,19:303-309. 28.Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med,2001,344:3-10. 29. Xiang-Hua Fang, Longstreth WT, Shi-Chuo Li, et al. Longitudinal Study of Blood Pressure and Stroke in over 37,000 People in China. Cerebrovasc Dis 2001;11:225-229. 30.Chinese Cardiac Study Group (Liu Lisheng , Wang Wen). Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks. Chinese Medical Journal,2001, 114(2): 115-118. 31. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet,2002,360:1903-1913. 32.se,S,l=NZ,I{. MSlu[RS-NQS2vxvz  PROGRESSTPATSՋSvQ4N^aIN. -NV;So[ R, 2002,4(5)382. 33. Kjeldsen SE, Dahlf B, Devereux RB, et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan intervention for Endpoint reduction (LIFE)substudy. JAMA,2002,288:1491-1498. 34.Dahlf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet,2002,359:995-1003. 35.Lindholm LH, Ibsen H, Dahlf B, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet,2002,359:1004-1010. 36.Wright JT, Bakris G, Greene T, et al. for the African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK Trial. JAMA, 2002,288:2421-2431. 37.The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA,2002,288:2998-3007. 38. -NVր]\O~pencGl;`RgOS\O~. -NVbNSO͑cpeTpV[vsQuuqSiV }_8^vKmNOs^,HO,I{. Nwm^bN N"~T_ AmLg. -NNS_@{uBg_ 2003,31:909-912. 45. Black HR, Elliot WJ, Grandist G, et al for the CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of cardiovascular Endpoints (CONVINCE) trial. JAMA,2003,289:2073-2082. 46.International Society of Hypertension. Statement on the management of blood pressure in acute stroke. J Hypertens,2003,21:665-672. 47.The European on reduction of cardiac events with perindopril in stable coronary artery disease investigators. Efficacy of perindopril in reduction cardiovascular events among with stabe coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study)[J] . Lancet, 2003, 362: 782-788. 48.Sever PS, Dahlf B, Poulter NR, et al for the ASCOT investigators. The prevention of coronary events and stroke with atorvastatin in hypertensive subjects with average or below average cholesterol levels. The Anglo-Scandinavian Cardiac Outcomes Trial: Lipid Lowering Arm (ASCOT: LLA). Lancet,2003,361:1149-1158. 49.4bg. _Rpzluve^y~QRl NOS. -NNS_@{uBg_,2003,31:1-2. 50.~NΘ,Ğ^R,UO_l,I{. -NV_RpzAmLuf[gSvQ`us. -NNS_@{uBg_, 2003,31:3-6. 51.se,RRu,pQu,I{.bV'Y7h,g:g4N^Ջlu_@{uvHeNċ0O. -NNS_@{uBg_,2003,31:24-28. 52.uQ. -NVNv@AmLuf[xvz. -NNS_@{uBg_,2003,31: 74-78. 53.4TFQς. bV_@{AmLuf[SU\30t^V~. -NNS_@{uBg_,2003,31:881-884. 54.RVN, leT. ؚ@SʋeTluxvzۏU\. -NNS_@{uBg_,2003,31:884-888. 55.hTSQ. NAmLuf[xvzpT4N^2l[. -NNS_@{uBg_,2003,31:891-892. 56. V[ ASN ;esQ Q_u0RS-N~TqSi^ċ0OSr^eHhvxvz ~.VN:@'`_@{uSuqSivċ0OelS{fċ0O]wQv_Sxvz. -NNS_@{uBg_, 2003,31:893-901. 57. _~_. -NVeP^NR 9_'`RSpexvz. -NNS_@{uBg_,2003,31(4):245-249. 58.m_\,gёy,f_m,I{. րTؚ@S`Tul NoN"_8^N\ }bbvsQ|. -NNS_@{uBg_, 2003,31(7):509-513. 59.~[NS. }V'`ؚ@Slu[V{. -NNS_@{uBg_, 2003,31(5):395-397. 60.4T!Bh,ky,Ğ^R. bVt^NUS~'`6e)gؚ@S`usSq_TV }.-NNS_@{uBg_,2003,31(6);456-459. 61.s[[,'YN. SNQrR uS%N͑'`vsQ|xvz.-NNS_@{uBg_,2003,31(2):83-86. 62.Ngez, }NS, _wm\,I{. MSlu[R Q-NB\S^TR z^'`q_Tvxvz. -NNS_@{uBg_,2003,31(4):254-256. 63. *P8le, _~_,s[[,I{. ؚ@Su dl^N SsQ|vxvz. -NNS_@{uBg_,2003,31(4):257-259. 64.s,uQ,RY,I{. -NV35~64\N_@{uqSiV }NSuqSiKm!jWvMRw'`xvz.-NNS_@{uBg_,2003,31:902-908. 65. RRu, _~_,ݐ^u,I{. ^m0Ws^ʑGr(Wؚ@Slu-NvhsT[hQ'`xvz.-NNS_@{uBg_,2004,32(4):291-294. 66.sbQ. ؚ@SNRS-N. -NNS_@{uBg_,2004,32(6):574-576. 67.RY, uQ,s,I{. -NVYw^_@{uqSiV }RxvzNV_f_xvz~gvk. -NNS_@{uBg_,2004,32(2):167-172. 68.fk30N,sXfk,ؚm. -NV;SukSuNXTؚ@S2l‰_T2lwƋg. -NNS_@{uBg_,2004,32(3):264-269. 69.]yKNf,hTf, _R,I{. N"~T_ _@{͑QXvyr_.-NNS_@{uBg_,2004,32(9):819-820. 70. [[,s,fk30N,I{. SN^WaN>y:SkSu gR-N_ؚ@S2lsrv[kxvz. -NNS_@{uBg_,2004,32(11):1021-1025. 71.s, uQ, Sx,I{. 1331NW~@S4ls^S10t^@SSSNR |7hlxSsQ|vxvz. -NNS_@{uBg_,2004,32(11):1017-1020. 72. _!`,1go. SS'`ؚ@SW Of[xvzvV{euTel. ؚ@SBg_,2004,12(1):4-8. 73. Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION):randomized controlled trial[J].Lancet, 2004,364(9437):849-857. 74. se,l=NZ,Rfl.MNO@S4ls^/f2_@{NNvsQ..-NV;So[ R 2004 64 259-261. 75.Lisheng Liu. The Study of hypertension in china. Blood Pressure,2004,13:72-74. 76.WHO consultation. Appropriate body mass index for Asian population and is implications for policy and intervention strategies. Lancet, 2004,363:157-116. 77.Nissen SE, Tuzcy EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trial [J]. JAMA, 2004, 292(18):2217-2226. 78.Julius S, Kjeldsen ES, Weber M, et al. the VALUE trial group Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet,2004,363(9426): 2022-2031. 79.Braunwald E, Domanski MJ, Fowler SE, et al for the PEACE trial investigators. Angiotensin-converting-enzyme inhibitors in stable coronary artery disease. [J]. N Engl J Med, 2005,351(20): 2058-2068. 80.hTSQ,fk30N,Ng,I{.-NVbN N"~T_ pVRpvxvz.-NNS_@{uBg_,2005,33(1): 81-85. 81.se,l=NZ,NgkS,I{. ACEb6RBRMSlu[_@{NNq_Tv:g4N^ՋvGl;`ċ0O. ؚ@SBg_ 2005,13:202-208. 82.Y[sOz,uQ,s,I{. SN0W:S2740Nv@S4ls^10t^(1992-2002)SS`Q.ؚ@SBg_, 2005,13(2):115-119. 83. s, s%f, z^h, I{. ؚ@Su4O N"~T_ `463Ovr^luxvz. -NNS_@{uBg_,2005,33(2):132-136. 84.RRu pQu se NhMSlu2RS-NQSxvzOS\O~. MSlu[-NV@{u`RS-NQS2vY-N_:gSv[gq4N^xvz.-NNS_@{uBg_,2005,337 :613-617. 85.1go. bVؚ@SWVxvzASt^V~TQp^.-NNS_@{uBg_ 2005 337 :585-587. 86.Jiang He, Dongfeng Gu, Xigui Wu, et al. Major Causes of Death among Men and Women in China. N Engl J Med 2005; 353:1124--1134. 87.Liu Lisheng Zhang Yuqing , Liu Guozhang ,et al, for FEVER Study Group. The Felodipine Event Reduction (FEVER) study : A randomized long-term placebo controlled trial in Chinese hypertensive patientsdesign and principle results. J Hypertens 2005,23 (suppl 2): S118  (*02NPVfhjygWG;1;15B*CJ\ph5B*CJ\o(ph5B*CJ\nHo(phtH5B*CJOJQJ\^Jph"5B*CJOJQJ\^Jo(ph(0JB*CJ,OJPJaJ nHo(phtH 0JB*CJ,OJPJaJ o(ph%0JB*CJ0OJPJaJ nHphtH0JB*CJ0OJPJaJ ph(0JB*CJ0OJPJaJ nHo(phtH 0JB*CJ0OJPJaJ o(ph/j0J5B*CJ0OJPJU\aJ o(ph2zfd_dddd$a$$1$7$VDWD8^`a$$L 1$7$VDWDH^L `a$Z$$IflB%%064 la$; $7$IfVDWDH^; `a$ ^   &(.4<DFHLRTV^dlrz "*,